The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
